Cargando…
SMAC Mimetics Synergistically Cooperate with HDAC Inhibitors Enhancing TNF-α Autocrine Signaling
SIMPLE SUMMARY: The combination of a SMAC mimetic with an HDAC inhibitor is a novel and promising strategy for cancer treatment. The HDAC inhibitor mechanistically synergizes with SMAC mimetics by stimulating autocrine TNF-α production. ABSTRACT: The overexpression of inhibitor of apoptosis (IAP) pr...
Autores principales: | Shibuya, Yusuke, Kudo, Kei, Zeligs, Kristen P., Anderson, David, Hernandez, Lidia, Ning, Franklin, Cole, Christopher B., Fergusson, Maria, Kedei, Noemi, Lyons, John, Taylor, Jason, Korrapati, Soumya, Annunziata, Christina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954505/ https://www.ncbi.nlm.nih.gov/pubmed/36831656 http://dx.doi.org/10.3390/cancers15041315 |
Ejemplares similares
-
Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian Cancer
por: Noonan, Anne M., et al.
Publicado: (2020) -
Smac-mimetic enhances antitumor effect of standard chemotherapy in ovarian cancer models via Caspase 8-independent mechanism
por: Hernandez, Lidia F., et al.
Publicado: (2021) -
Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis
por: Welsh, Kate, et al.
Publicado: (2016) -
Future Therapeutic Directions for Smac-Mimetics
por: Morrish, Emma, et al.
Publicado: (2020) -
Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib
por: Lecis, D, et al.
Publicado: (2010)